Monocytes in low-risk MDS groups have been implicated with the increased transcription of pro-inflammatory genes and the associated production of cytokines such as S100A9, IL-1B and NLRP3 further emphasizing their influence on the dysregulation of the normal bone marrow niche. The gene discussed is IL1B; the disease is myelodysplastic syndrome.